Basalt Health raises $20M Series A to speed AI post-acute admissions

Basalt Health, the AI layer for post-acute care admissions, announced a $20 million Series A led by return investor NEA, with Frist Cressey Ventures and 25m Health participating. Total capital raised is about $24.5 million. The platform reads referral packets by fax, portal, or a direct link to the electronic medical record and checks them against clinical and payer rules so clinicians can make faster, cited admit decisions.

HEALTH desk — a patient who is ready to leave the hospital can still sit in that bed while a case manager faxes a long chart to several nursing homes and waits for one of them to say yes. Basalt’s announcement is software that reads the referral as it arrives, flags risks such as dialysis, a psychiatric hold, or whether the patient looks medically stable, and cites the line in the packet. The clinician still makes the admit call.

What the line above the lede says, and what the highlights say the round is. The italic line says the AI platform reduces referral processing time by 86% at Lifepoint Health and will scale across 62 ScionHealth hospitals by the end of 2026. The highlights say a $20 million Series A led by NEA, with participation from Frist Cressey Ventures and 25m Health. They say the platform reduces median processing time 86%, from 8.5 minutes to 1.2 minutes, at Lifepoint Health, called a leading diversified healthcare delivery network. They say the new capital will fuel product expansion and help scale across 111 markets, 62 ScionHealth and 49 Lifepoint Health, by the end of 2026. Leading, and 86%, are the page’s words. This desk did not rank hospital companies.

What the lede says the money is. Basalt Health, called the AI platform that helps patients transition to post-acute care faster, today announced a $20 million Series A financing led by return investor NEA, with participation from existing investors Frist Cressey Ventures and 25m Health. The round brings the company’s total capital raised to approximately $24.5 million. Post-acute care, here, is the care after a hospital stay, such as a nursing facility or a rehab bed. Return investor means NEA had already put money in. Existing investors means the other two were already in. Those glosses are this desk’s. Twenty million dollars, and about $24.5 million in total, are the release’s figures. This desk did not see a term sheet.

Why the release says patients wait, and whose figures those are. Each year, roughly 14 million patients enter post-acute care, and the release says the placement process has failed to evolve. The process it describes is case managers faxing lengthy clinical packets to 6.6 facilities per placement, then waiting for the right bed to respond. The resulting delays and mismatches contribute to an estimated $17 billion in avoidable readmission costs annually. A case manager, here, is the person who finds the next bed. A readmission is a patient who lands back in the hospital. Those glosses are this desk’s. Roughly 14 million, 6.6 facilities, and the estimated $17 billion are the release’s. This desk did not count the faxes or audit the cost.

Ben Hackett, as a quote, not as a measured wait. Ben Hackett, Founder and CEO of Basalt Health, said case managers are still sending 70-page packets and waiting for responses, while patients remain stranded in hospital beds. He said Basalt turns that uncertainty into fast, defensible decisions. He said this funding gives them the power to transform one of healthcare’s most stubbornly inefficient systems. Seventy pages is his number. Fast and defensible are his words. They are not a timer or a legal review this desk ran. The homepage later shows an 86-page fax as a product example. Do not collapse 70 and 86. This desk did not interview him.

The biography the release prints, and what this desk did not check. The release says the mission is personal: a mother and a grandmother who were nurses, nearly a decade at Accolade, where he saw administrative work pull clinicians away from patients, and a company founded in 2024 to build technology that fits existing workflows. A clinician, here, is a doctor, a nurse, or another person licensed to make the care decision. That gloss is this desk’s. The family, the decade, Accolade, and 2024 are the release’s sentences. This desk did not read a résumé.

What the release says the software does. Basalt reads every referral as it arrives, whether by fax, portal, or direct EMR integration, and evaluates it against a facility’s clinical criteria. It then supports the workflows that follow, including admissions, benefits checks, and prior authorizations. EMR is the electronic medical record, the chart. A portal is a website a hospital already uses to send referrals. A prior authorization is the payer’s approval before it will cover a stay or a service. A benefits check is a look at what the patient’s insurance will pay. Those glosses are this desk’s. The release says that instead of simply moving documents, Basalt helps care teams reach fast, consistent, and defensible placement decisions. Consistent and defensible are the release’s words. This desk did not open a referral queue.

Blake Wu, as a quote. Blake Wu, Partner at NEA and Basalt Health board member, said Basalt is tackling a massive healthcare challenge with a rare combination of clinical impact, operational value, and rapid adoption. He said the platform is becoming essential infrastructure for care teams, and that NEA is thrilled to continue its partnership with Ben and the Basalt team. Essential, and rapid adoption, are his sentences. They are not a customer count this desk made. The quote’s title calls him a board member. This desk did not see a separate document that says he is joining the board on this day. This desk did not interview him.

Merrill Anovick, as a quote. Merrill Anovick, General Partner at 25madison and Basalt Health Board Member, said Basalt is what they mean when they say AI should disappear into the workflow. He said case managers don’t see a chatbot. They see the right bed, faster, with a clear reason behind the decision. He said Ben and the team have made AI reliable on the documents healthcare actually runs on, and that is why two major health systems are scaling it network-wide. A chatbot, here, is a box you type questions into. Disappear into the workflow means the person keeps working in the tools they already have. Those glosses are this desk’s. Two major health systems is his count. The release names Lifepoint and ScionHealth. This desk did not interview him.

What Lifepoint’s numbers are, and whose percent that is. Basalt has been live with Lifepoint Health’s team since its seed round in 2025, reducing median chart processing time from 8.5 minutes to 1.2 minutes. The release also says Basalt is being implemented across 49 additional Lifepoint markets by the end of 2026. Median, here, means the middle chart, not the average. A market, here, is a place the health system operates, as the release uses the word. Those glosses are this desk’s. The highlights call the drop an 86% reduction. Eight and a half minutes minus 1.2 minutes is 7.3 minutes. 7.3 divided by 8.5 is about 86 percent. That arithmetic is this desk’s check of the two times the release prints. The 86% is the release’s label. 1.2 minutes is 72 seconds. The homepage’s separate line, 72 seconds to read an 86-page fax, is not this Lifepoint median. Do not collapse them. This desk did not time a chart.

Al Smith, as a quote. Al Smith, Senior Vice President and Chief Information Officer of Lifepoint Health, said Basalt is the kind of innovation healthcare needs right now: technology that creates measurable value while fitting naturally into existing clinical and operational workflows. He said the platform helps organizations identify opportunities sooner, streamline operations and patient access, and support better outcomes without increasing the burden on frontline teams. Measurable value, and better outcomes, are his sentences. They are not a study this desk read past the 8.5-to-1.2 line already quoted. This desk did not interview him.

What the release says about ScionHealth, and the quote whose opening mark is broken. The platform is scaling to 62 ScionHealth hospitals by the end of 2026, where it will manage every incoming referral across a network of more than 6,000 practitioners. A practitioner, here, is a clinician in that network. That gloss is this desk’s. Every incoming referral is the release’s claim. Sarah Stuart, SVP Growth and Transformation at ScionHealth, is quoted next. On the syndication this desk read, the opening quotation mark is two Unicode replacement characters, not a word this desk restored. The sentence that follows is: What started as a new technology platform with an innovation partner, has quickly transformed how our team members’ work every day. She said Basalt helps teams work faster, make more informed decisions, and deliver a better experience for patients and partners. Faster, and a better experience, are her sentences. This desk did not interview her.

What the money is for, and the two clocks on 62 hospitals. Basalt will use the funding to expand the platform from admissions into discharge and payer workflows and to grow its sales, marketing, implementation, and engineering teams. Discharge is the plan for leaving the hospital. A payer workflow is the paperwork with the insurer. Those glosses are this desk’s. The body says ScionHealth scale is by the end of 2026. The about box says scaling to 62 hospitals with ScionHealth by December 2026. End of 2026 and December 2026 are both on the release. This desk did not treat them as two different go-live dates. The highlights’ 111 markets are printed as 62 ScionHealth and 49 Lifepoint. 62 plus 49 is 111. That addition is this desk’s check of the parenthetical.

What the card shows, and what the wire does not print. The card is the Intake packet panel on basalt.health, the ED referral marked 1 of 24 pages, framed with Basalt’s ink side rails and sky bars. The top rail reads Basalt · Intake. The packet is an emergency-department referral from Riverside General Hospital. The chart text is a 54-year-old man brought in with acute agitation and suicidal ideation, placed on a 72-hour involuntary hold, with daily heavy alcohol use, a CIWA-Ar score of 18, end-stage renal disease on hemodialysis three times a week, and a note that he is medically stable and walking on his own. CIWA-Ar is the chart’s name for an alcohol-withdrawal score. Hemodialysis is a machine that filters the blood when the kidneys no longer do that job. End-stage renal disease means the kidneys have failed. An involuntary hold means the patient is not free to leave yet. Those glosses are this desk’s. The words are the product page’s. The 24 Sep release does not print Riverside General, the 54-year-old, or CIWA-Ar 18. The same page’s other panel, What Basalt surfaces, flags an active dialysis requirement as a risk, the 72-hour hold as something to review, and medical stability and functional independence as likely, each with a source citation. A line under that panel says the patient is synthetic, that Basalt surfaces the evidence, and that the clinician makes the call. Synthetic means the chart is an example, not a person this desk can identify. That gloss is this desk’s. The sentence is the page’s. It is not printed on this card. The page also says 72 seconds to read and check an 86-page faxed referral, and 73% faster from referral received to an admit decision. Those two figures are the homepage’s. The wire’s 1.2 minutes is Lifepoint’s median chart time. Do not collapse them. The card has no desk date on it.

Plain English for the rest of the card. A Series A is a funding round after a company has a product in use. Twenty million dollars is the new money. About $24.5 million is the total the release says the company has raised. NEA led, and it is described as a return investor. Frist Cressey Ventures and 25m Health were already investors. Post-acute care is the bed after the hospital. The release’s picture of the old process is a fax to 6.6 facilities and an estimated $17 billion a year in avoidable readmissions, on roughly 14 million patients. Lifepoint’s middle chart went from 8.5 minutes to 1.2 minutes, which the release calls an 86% cut, with 49 more Lifepoint markets and 62 ScionHealth hospitals in the scale plan by the end of 2026. The about box says December 2026 for those 62 hospitals. The money also goes to discharge and payer work, and to hiring. The card is a made-up emergency referral, and the page says a clinician still decides. 8:00 AM EDT is 8:00 a.m. Eastern and 12:00 p.m. UTC. Rachel Stevens, Marketing Director, is the media contact at rachel.stevens@basalt.health. This filing is the 24 Sep announcement.

PRIMARY here: Basalt’s 24 Sep 2026 Business Wire, release 20260924615578, stamped September 24th 2026, 8:00 AM EDT on the FinancialContent syndication this desk read — Tier A PRIMARY, the company’s own announcement. STATUS PRIMARY. businesswire.com itself did not return a page. The $20 million, NEA as return investor, Frist Cressey Ventures, 25m Health, approximately $24.5 million total, the 14 million patients, 6.6 facilities, the estimated $17 billion, the Hackett quote including 70-page packets, the biography, fax portal and EMR, admissions benefits and prior authorization, the Wu quote, the Anovick quote, Lifepoint since the 2025 seed, 8.5 minutes to 1.2 minutes, the 86% label, 49 additional Lifepoint markets, the Smith quote, 62 ScionHealth hospitals, more than 6,000 practitioners, the Stuart quote, discharge and payer workflows, the hiring line, the about box including December 2026, and rachel.stevens@basalt.health are that release’s. Riverside General, the 54-year-old chart, CIWA-Ar 18, the dialysis risk, the hold review, the likely flags, the synthetic-patient line, 72 seconds, 73% faster, and the 86-page fax example are the product page’s. NOT claimed: a term sheet this desk saw, that 14 million or $17 billion was recounted here, that 70 pages and 86 pages are the same packet, that 1.2 minutes and 72 seconds are the same clock, that Wu’s board title is a same-day appointment letter, that the Stuart opening mark was a word, that Riverside General is a real patient, a login, a stock tip, or investment advice. The card is the Intake packet. Distinct from the already-filed workday-total-benefits, assort-health-primary-care, and veeva-study-builder-agent.